Novartis Access-to-medicine programs reached approximately 52 million patients, including first-year deliveries through the innovative Novartis Access program
Novartis improved position in key sustainability rankings, including recent Corporate Knights’ “Global 100 Most Sustainable Corporations in the World"
2016 report highlights work towards the United Nations Sustainable Development Goals and shares trends and challenges within the healthcare industry
Basel, January 26, 2017 – Novartis published its Corporate Responsibility (CR) Performance Report for the fourth consecutive year, highlighting progress on access and environmental goals in 2016. Building on the company’s long history of corporate responsibility and transparent reporting, the 2016 report provides even more context on the company’s CR performance across five key areas: Access, Ethics, Research & Development, People and Environment. The report also captures perspectives from external stakeholders on trends and challenges within the healthcare industry and presents the essential contributions Novartis makes to the United Nations Sustainable Development Goals.